Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Astellas, MSD Seek Japan Nod for Padcev/Keytruda in Perioperative MIBC
February 2, 2026
- Alfresa Launches End-to-End Platform to Support Biotech Entry into Japan
February 2, 2026
- Nichi-Iko’s Xarelto Generic Adds VTE Use
February 2, 2026
- Ohara Files Japan NDA for Jazz’s Diffuse Midline Glioma Drug
February 2, 2026
- Takeda Files ImmunoGen-Paired ADC for Ovarian Cancer in Japan
February 2, 2026
- Fuji Says Eylea Biosimilar Patent Risk Cleared under Global Settlement
February 2, 2026
- Takeda Rejigs Structure Ahead of CEO Transition, Creates New International Unit
January 30, 2026
- FDA Places Clinical Hold on MPS Gene Therapies: Regenxbio/Nippon Shinyaku
January 30, 2026
- Astellas Positions Izervay as Key Entry Drug in Ophthalmology Push
January 30, 2026
- Chugai Logs Solid 2025 Results on Overseas Growth, Profit Margin Nears 50%
January 30, 2026
- Zynlonta Hits Primary Endpoint in Japanese PI/II Study: Tanabe
January 30, 2026
- Towa Chief Urges Better Use of Innovators’ LLP Manufacturing Assets, Calls Otsuka Deal a “First Step”
January 30, 2026
- Takeda Raises Full-Year Forecast on Weaker Yen Assumptions
January 30, 2026
- Chugai Files Tecentriq in Adjuvant Use for MRD-Positive Bladder Cancer
January 29, 2026
- Otsuka’s Centanafadine Accepted for FDA Review with Priority Tag
January 28, 2026
- Sato Enters Smoking Cessation Market via Nicotinell Tie-Up with Dr. Reddy’s
January 27, 2026
- Top Court Rejects Samsung Challenge to Patent-Linkage Disclosures in Eylea Biosimilar Case
January 27, 2026
- Quviviq, Dayvigo Top 3 Promotion Channels in December: Intage
January 27, 2026
- Ajinomoto Builds Presence in ADC CDMO Business with Proprietary Technology
January 27, 2026
- Leqembi Iqlik Now under FDA Review for Initiation Phase
January 26, 2026
ページ
Japan is opening a new chapter in sleep medicine. The recent decision to allow medical institutions to advertise “sleep disorders”…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…